Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
an expired dose of Menveo 1-vial was administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a adult male patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 22-JUL-2025, the patient received Menveo. On 22-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: an expired dose of Menveo 1-vial was administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-JUL-2025 The pharmacist reported that an expired dose of Menveo 1-vial was administered to the patient, which led to expired vaccine used. The reporter was looking for information regarding expiration date on a vaccine and how long after the expiration date and asked were they good for and efficacy.